カテゴリー： 世界, 医療/バイオ, QYResearch

完全埋め込み型静脈内投与装置（TIVAD）の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Totally Implantable Intravenous Device (TIVAD) Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10180）・商品コード：QY22JLX10180
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、完全埋め込み型静脈内投与装置（TIVAD）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に完全埋め込み型静脈内投与装置（TIVAD）の世界市場のxxx％を占める「チタン製ポートボディ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
完全埋め込み型静脈内投与装置（TIVAD）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの完全埋め込み型静脈内投与装置（TIVAD）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

完全埋め込み型静脈内投与装置（TIVAD）のグローバル主要企業には、C.R. Bard、AngioDynamics、Smiths Medical、Bard Access Systems、B. Braun、Teleflex、Cook Medical、Fresenius Kabi、PFM Medical、Vygon、Districlass、PakuMed、MedComp、Navilyst Medical、Norfolk Medical Products、Suzhou Linhwa Medical Devices、Weigao Holding、Guangdong Baihe Medical Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

完全埋め込み型静脈内投与装置（TIVAD）市場は、種類と用途によって区分されます。世界の完全埋め込み型静脈内投与装置（TIVAD）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
チタン製ポートボディ、プラスチック製ポートボディ

【用途別セグメント】
がん、末期腎不全、糖尿病

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 完全埋め込み型静脈内投与装置（TIVAD）製品概要
- 種類別市場（チタン製ポートボディ、プラスチック製ポートボディ）
- 用途別市場（がん、末期腎不全、糖尿病）
- 調査の目的
・エグゼクティブサマリー
- 世界の完全埋め込み型静脈内投与装置（TIVAD）販売量予測2017-2028
- 世界の完全埋め込み型静脈内投与装置（TIVAD）売上予測2017-2028
- 完全埋め込み型静脈内投与装置（TIVAD）の地域別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）販売量
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）売上
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（チタン製ポートボディ、プラスチック製ポートボディ）
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別売上
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別価格
・用途別市場規模（がん、末期腎不全、糖尿病）
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別売上
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別価格
・北米市場
- 北米の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（トルコ、サウジアラビア）
・企業情報
C.R. Bard、AngioDynamics、Smiths Medical、Bard Access Systems、B. Braun、Teleflex、Cook Medical、Fresenius Kabi、PFM Medical、Vygon、Districlass、PakuMed、MedComp、Navilyst Medical、Norfolk Medical Products、Suzhou Linhwa Medical Devices、Weigao Holding、Guangdong Baihe Medical Technology
・産業チェーン及び販売チャネル分析
- 完全埋め込み型静脈内投与装置（TIVAD）の産業チェーン分析
- 完全埋め込み型静脈内投与装置（TIVAD）の原材料
- 完全埋め込み型静脈内投与装置（TIVAD）の生産プロセス
- 完全埋め込み型静脈内投与装置（TIVAD）の販売及びマーケティング
- 完全埋め込み型静脈内投与装置（TIVAD）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 完全埋め込み型静脈内投与装置（TIVAD）の産業動向
- 完全埋め込み型静脈内投与装置（TIVAD）のマーケットドライバー
- 完全埋め込み型静脈内投与装置（TIVAD）の課題
- 完全埋め込み型静脈内投与装置（TIVAD）の阻害要因
・主な調査結果

The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.
Market Analysis and Insights: Global Totally Implantable Intravenous Device (TIVAD) Market
Due to the COVID-19 pandemic, the global Totally Implantable Intravenous Device (TIVAD) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Titanium Port Body accounting for % of the Totally Implantable Intravenous Device (TIVAD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Totally Implantable Intravenous Device (TIVAD) market size is valued at US$ million in 2021, while the US and Europe Totally Implantable Intravenous Device (TIVAD) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Totally Implantable Intravenous Device (TIVAD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Totally Implantable Intravenous Device (TIVAD) include C.R. Bard, AngioDynamics, Smiths Medical, Bard Access Systems, B. Braun, Teleflex, Cook Medical, Fresenius Kabi and PFM Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Totally Implantable Intravenous Device (TIVAD) Scope and Segment
Totally Implantable Intravenous Device (TIVAD) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Totally Implantable Intravenous Device (TIVAD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Titanium Port Body
Plastic Port Body
Segment by Application
Cancer
End-Stage Renal Disease
Diabetes
By Company
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
Guangdong Baihe Medical Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Totally Implantable Intravenous Device (TIVAD) Product Introduction
1.2 Market by Type
1.2.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Titanium Port Body
1.2.3 Plastic Port Body
1.3 Market by Application
1.3.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 End-Stage Renal Disease
1.3.4 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Estimates and Forecasts 2017-2028
2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Estimates and Forecasts 2017-2028
2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region
2.4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022)
2.4.2 Global Sales Totally Implantable Intravenous Device (TIVAD) by Region (2023-2028)
2.5 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region
2.5.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022)
2.5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Manufacturers
3.1.1 Global Top Totally Implantable Intravenous Device (TIVAD) Manufacturers by Sales (2017-2022)
3.1.2 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Totally Implantable Intravenous Device (TIVAD) in 2021
3.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturers
3.2.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturers (2017-2022)
3.2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Totally Implantable Intravenous Device (TIVAD) Revenue in 2021
3.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Totally Implantable Intravenous Device (TIVAD) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Type
4.1.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Sales by Type (2017-2022)
4.1.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Sales by Type (2023-2028)
4.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
4.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type
4.2.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Revenue by Type (2017-2022)
4.2.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
4.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Type
4.3.1 Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2022)
4.3.2 Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Application
5.1.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Sales by Application (2017-2022)
5.1.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Sales by Application (2023-2028)
5.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application
5.2.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Revenue by Application (2017-2022)
5.2.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
5.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Application
5.3.1 Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2022)
5.3.2 Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Type
6.1.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
6.1.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
6.2 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Application
6.2.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
6.2.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
6.3 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Country
6.3.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
6.3.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Type
7.1.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
7.1.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
7.2 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Application
7.2.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
7.2.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
7.3 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Country
7.3.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
7.3.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Type
8.1.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
8.1.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
8.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Application
8.2.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
8.2.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
8.3 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Region
8.3.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2028)
8.3.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Type
9.1.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
9.1.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
9.2 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Application
9.2.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
9.2.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
9.3 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Country
9.3.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
9.3.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Type
10.1.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
10.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Application
10.2.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
10.3 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Country
10.3.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 C.R. Bard
11.1.1 C.R. Bard Corporation Information
11.1.2 C.R. Bard Overview
11.1.3 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 C.R. Bard Recent Developments
11.2 AngioDynamics
11.2.1 AngioDynamics Corporation Information
11.2.2 AngioDynamics Overview
11.2.3 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AngioDynamics Recent Developments
11.3 Smiths Medical
11.3.1 Smiths Medical Corporation Information
11.3.2 Smiths Medical Overview
11.3.3 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Smiths Medical Recent Developments
11.4 Bard Access Systems
11.4.1 Bard Access Systems Corporation Information
11.4.2 Bard Access Systems Overview
11.4.3 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bard Access Systems Recent Developments
11.5 B. Braun
11.5.1 B. Braun Corporation Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 B. Braun Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 Teleflex
11.6.1 Teleflex Corporation Information
11.6.2 Teleflex Overview
11.6.3 Teleflex Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teleflex Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teleflex Recent Developments
11.7 Cook Medical
11.7.1 Cook Medical Corporation Information
11.7.2 Cook Medical Overview
11.7.3 Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cook Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cook Medical Recent Developments
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Corporation Information
11.8.2 Fresenius Kabi Overview
11.8.3 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fresenius Kabi Recent Developments
11.9 PFM Medical
11.9.1 PFM Medical Corporation Information
11.9.2 PFM Medical Overview
11.9.3 PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PFM Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PFM Medical Recent Developments
11.10 Vygon
11.10.1 Vygon Corporation Information
11.10.2 Vygon Overview
11.10.3 Vygon Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vygon Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vygon Recent Developments
11.11 Districlass
11.11.1 Districlass Corporation Information
11.11.2 Districlass Overview
11.11.3 Districlass Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Districlass Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Districlass Recent Developments
11.12 PakuMed
11.12.1 PakuMed Corporation Information
11.12.2 PakuMed Overview
11.12.3 PakuMed Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 PakuMed Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PakuMed Recent Developments
11.13 MedComp
11.13.1 MedComp Corporation Information
11.13.2 MedComp Overview
11.13.3 MedComp Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 MedComp Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MedComp Recent Developments
11.14 Navilyst Medical
11.14.1 Navilyst Medical Corporation Information
11.14.2 Navilyst Medical Overview
11.14.3 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Navilyst Medical Recent Developments
11.15 Norfolk Medical Products
11.15.1 Norfolk Medical Products Corporation Information
11.15.2 Norfolk Medical Products Overview
11.15.3 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Norfolk Medical Products Recent Developments
11.16 Suzhou Linhwa Medical Devices
11.16.1 Suzhou Linhwa Medical Devices Corporation Information
11.16.2 Suzhou Linhwa Medical Devices Overview
11.16.3 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Suzhou Linhwa Medical Devices Recent Developments
11.17 Weigao Holding
11.17.1 Weigao Holding Corporation Information
11.17.2 Weigao Holding Overview
11.17.3 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Weigao Holding Recent Developments
11.18 Guangdong Baihe Medical Technology
11.18.1 Guangdong Baihe Medical Technology Corporation Information
11.18.2 Guangdong Baihe Medical Technology Overview
11.18.3 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Guangdong Baihe Medical Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Totally Implantable Intravenous Device (TIVAD) Industry Chain Analysis
12.2 Totally Implantable Intravenous Device (TIVAD) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Totally Implantable Intravenous Device (TIVAD) Production Mode & Process
12.4 Totally Implantable Intravenous Device (TIVAD) Sales and Marketing
12.4.1 Totally Implantable Intravenous Device (TIVAD) Sales Channels
12.4.2 Totally Implantable Intravenous Device (TIVAD) Distributors
12.5 Totally Implantable Intravenous Device (TIVAD) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Totally Implantable Intravenous Device (TIVAD) Industry Trends
13.2 Totally Implantable Intravenous Device (TIVAD) Market Drivers
13.3 Totally Implantable Intravenous Device (TIVAD) Market Challenges
13.4 Totally Implantable Intravenous Device (TIVAD) Market Restraints
14 Key Findings in The Global Totally Implantable Intravenous Device (TIVAD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Titanium Port Body
Table 3. Major Manufacturers of Plastic Port Body
Table 4. Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022) & (K Units)
Table 7. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2017-2022)
Table 8. Global Totally Implantable Intravenous Device (TIVAD) Sales by Region (2023-2028) & (K Units)
Table 9. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2023-2028)
Table 10. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region (2017-2022)
Table 12. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region (2023-2028)
Table 14. Global Totally Implantable Intravenous Device (TIVAD) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Manufacturers (2017-2022)
Table 16. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Manufacturers (2017-2022)
Table 18. Totally Implantable Intravenous Device (TIVAD) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Totally Implantable Intravenous Device (TIVAD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Totally Implantable Intravenous Device (TIVAD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Totally Implantable Intravenous Device (TIVAD) as of 2021)
Table 21. Totally Implantable Intravenous Device (TIVAD) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Totally Implantable Intravenous Device (TIVAD) Product Offered
Table 23. Date of Manufacturers Enter into Totally Implantable Intravenous Device (TIVAD) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 26. Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 27. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Type (2017-2022)
Table 28. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Type (2023-2028)
Table 29. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Type (2017-2022)
Table 32. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Type (2023-2028)
Table 33. Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 36. Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 37. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Application (2017-2022)
Table 38. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Application (2023-2028)
Table 39. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Application (2017-2022)
Table 42. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Application (2023-2028)
Table 43. Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 46. North America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 47. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 50. North America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 51. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
Table 54. North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2023-2028) & (K Units)
Table 55. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 58. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 59. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 62. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 63. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
Table 66. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2023-2028) & (K Units)
Table 67. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2023-2028) & (US$ Million)
Table 105. C.R. Bard Corporation Information
Table 106. C.R. Bard Description and Major Businesses
Table 107. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. C.R. Bard Recent Developments
Table 110. AngioDynamics Corporation Information
Table 111. AngioDynamics Description and Major Businesses
Table 112. AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AngioDynamics Recent Developments
Table 115. Smiths Medical Corporation Information
Table 116. Smiths Medical Description and Major Businesses
Table 117. Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Smiths Medical Recent Developments
Table 120. Bard Access Systems Corporation Information
Table 121. Bard Access Systems Description and Major Businesses
Table 122. Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bard Access Systems Recent Developments
Table 125. B. Braun Corporation Information
Table 126. B. Braun Description and Major Businesses
Table 127. B. Braun Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. B. Braun Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. B. Braun Recent Developments
Table 130. Teleflex Corporation Information
Table 131. Teleflex Description and Major Businesses
Table 132. Teleflex Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Teleflex Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Teleflex Recent Developments
Table 135. Cook Medical Corporation Information
Table 136. Cook Medical Description and Major Businesses
Table 137. Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Cook Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Cook Medical Recent Developments
Table 140. Fresenius Kabi Corporation Information
Table 141. Fresenius Kabi Description and Major Businesses
Table 142. Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Fresenius Kabi Recent Developments
Table 145. PFM Medical Corporation Information
Table 146. PFM Medical Description and Major Businesses
Table 147. PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. PFM Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. PFM Medical Recent Developments
Table 150. Vygon Corporation Information
Table 151. Vygon Description and Major Businesses
Table 152. Vygon Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Vygon Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Vygon Recent Developments
Table 155. Districlass Corporation Information
Table 156. Districlass Description and Major Businesses
Table 157. Districlass Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Districlass Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Districlass Recent Developments
Table 160. PakuMed Corporation Information
Table 161. PakuMed Description and Major Businesses
Table 162. PakuMed Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. PakuMed Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. PakuMed Recent Developments
Table 165. MedComp Corporation Information
Table 166. MedComp Description and Major Businesses
Table 167. MedComp Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. MedComp Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. MedComp Recent Developments
Table 170. Navilyst Medical Corporation Information
Table 171. Navilyst Medical Description and Major Businesses
Table 172. Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Navilyst Medical Recent Developments
Table 175. Norfolk Medical Products Corporation Information
Table 176. Norfolk Medical Products Description and Major Businesses
Table 177. Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Norfolk Medical Products Recent Developments
Table 180. Suzhou Linhwa Medical Devices Corporation Information
Table 181. Suzhou Linhwa Medical Devices Description and Major Businesses
Table 182. Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Suzhou Linhwa Medical Devices Recent Developments
Table 185. Weigao Holding Corporation Information
Table 186. Weigao Holding Description and Major Businesses
Table 187. Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 188. Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Weigao Holding Recent Developments
Table 190. Guangdong Baihe Medical Technology Corporation Information
Table 191. Guangdong Baihe Medical Technology Description and Major Businesses
Table 192. Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 193. Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Guangdong Baihe Medical Technology Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Totally Implantable Intravenous Device (TIVAD) Distributors List
Table 198. Totally Implantable Intravenous Device (TIVAD) Customers List
Table 199. Totally Implantable Intravenous Device (TIVAD) Market Trends
Table 200. Totally Implantable Intravenous Device (TIVAD) Market Drivers
Table 201. Totally Implantable Intravenous Device (TIVAD) Market Challenges
Table 202. Totally Implantable Intravenous Device (TIVAD) Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Totally Implantable Intravenous Device (TIVAD) Product Picture
Figure 3. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Type in 2021 & 2028
Figure 3. Titanium Port Body Product Picture
Figure 4. Plastic Port Body Product Picture
Figure 5. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Application in 2021 & 2028
Figure 6. Cancer
Figure 7. End-Stage Renal Disease
Figure 8. Diabetes
Figure 9. Totally Implantable Intravenous Device (TIVAD) Report Years Considered
Figure 10. Global Totally Implantable Intravenous Device (TIVAD) Sales 2017-2028 (K Units)
Figure 11. Global Totally Implantable Intravenous Device (TIVAD) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Totally Implantable Intravenous Device (TIVAD) Revenue 2017-2028 (US$ Million)
Figure 13. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2017-2022)
Figure 15. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2023-2028)
Figure 16. North America Totally Implantable Intravenous Device (TIVAD) Sales YoY (2017-2028) & (K Units)
Figure 17. North America Totally Implantable Intravenous Device (TIVAD) Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Totally Implantable Intravenous Device (TIVAD) Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Totally Implantable Intravenous Device (TIVAD) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Totally Implantable Intravenous Device (TIVAD) Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Totally Implantable Intravenous Device (TIVAD) Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Totally Implantable Intravenous Device (TIVAD) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Totally Implantable Intravenous Device (TIVAD) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Totally Implantable Intravenous Device (TIVAD) in the World: Market Share by Totally Implantable Intravenous Device (TIVAD) Revenue in 2021
Figure 28. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 30. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 31. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 32. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 33. North America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 34. North America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 35. North America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 36. North America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 37. North America Totally Implantable Intravenous Device (TIVAD) Sales Share by Country (2017-2028)
Figure 38. North America Totally Implantable Intravenous Device (TIVAD) Revenue Share by Country (2017-2028)
Figure 39. United States Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 42. Europe Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 43. Europe Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 44. Europe Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 45. Europe Totally Implantable Intravenous Device (TIVAD) Sales Share by Country (2017-2028)
Figure 46. Europe Totally Implantable Intravenous Device (TIVAD) Revenue Share by Country (2017-2028)
Figure 47. Germany Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 48. France Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue Share by Region (2017-2028)
Figure 58. China Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 61. India Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 68. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 70. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Totally Implantable Intravenous Device (TIVAD) Sales Share by Country (2017-2028)
Figure 72. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue Share by Country (2017-2028)
Figure 73. Mexico Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue Share by Country (2017-2028)
Figure 83. Turkey Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Totally Implantable Intravenous Device (TIVAD) Revenue (2017-2028) & (US$ Million)
Figure 86. Totally Implantable Intravenous Device (TIVAD) Value Chain
Figure 87. Totally Implantable Intravenous Device (TIVAD) Production Process
Figure 88. Channels of Distribution
Figure

★調査レポート[完全埋め込み型静脈内投与装置（TIVAD）の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10180)販売に関する免責事項を必ずご確認ください。
★調査レポート[完全埋め込み型静脈内投与装置（TIVAD）の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の完全埋め込み型静脈アクセス装置市場予測2023-2029：チタン注入ポート、プラスチック注入ポート
  • 女性用外部尿収集装置（EUCD）の世界市場インサイト・予測（～2028年）
  • 低侵襲手術器具＆付属品（MISIA）の世界市場インサイト・予測（～2028年）
  • 自動警備員支援装置（AFAD）の世界市場インサイト・予測（～2028年）
  • 医療アンデルセンカスケードインパクター（ACI）の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆